The third stop of the "Developing Organoids·Benefiting the Country" ev...
BioGenous Biotech conducted the symposium on organoid technology and translational research at the Institute of Translational Medicine, Shenzhen Second People’s Hospital (First Affiliated Hospital of Shenzhen University). During the event, Professor Bing Zhao, Chief Scientist of BioGenous Biotech and professor at Fudan University, delivered a keynote presentation titled "Human Organoids Modeling Development and Disease." Researcher Weiren Huang, Deputy Director of the Institute of Translational Medicine and Head of the Department of Academic Development at Shenzhen Second People’s Hospital, presented on "Establishment and Application of Tumor Organoids." Both parties engaged in in-depth discussions about organoid research and its translational applications. At the symposium, BioGenous Biotech and the Institute of Translational Medicine, Shenzhen Second People’s Hospital (First Affiliated Hospital of Shenzhen University) reached several agreements on collaborative efforts in fundamental organoid research and identified breakthroughs and future directions for clinical applications.